HOME >> BIOLOGY >> NEWS
Campbell wins 2004 Abbott-ASM Lifetime Achievement Award

Allan M. Campbell, Ph.D., Professor of Biological Sciences and Barbara Kimball Browning Professor in the School of Humanities and Sciences, Stanford University, Stanford, California, will receive the 2004 Abbott-ASM Lifetime Achievement Award, proudly supported by Abbott Laboratories, from the American Society for Microbiology (ASM). Campbell is honored for his exceptional insights and achievements in the field of molecular genetics, a career of groundbreaking research that has had a profound influence on several fields, including molecular cloning and gene therapy. At the ASM General Meeting, he will deliver the Abbott-ASM Award Lecture, "Unity and Diversity in Lysogeny."

One of Campbell's most celebrated accomplishments was demonstrating the relationship between the genome of bacteriophage lambda (one of a group of viruses that attack bacteria) and its host. In the 1950s, he concluded that bacteriophage lambda associates with and dissociates from its host by inserting and removing a circular viral genome, or set of genes, into the bacterial chromosome. This finding, known as the Campbell model, has led the way for genetic and biochemical studies of site-specific recombination, the exchange of genetic information between the genomes of different species. It also stands as a landmark precursor of current research on the manipulation of genomes.

These early studies led to other noted achievements, including Campbell's discovery of nonsense mutations and important work on bacterial gene regulation. His studies of microbial population dynamics and the evolution of genome structure have increased microbiologists' understanding of such questions as how viruses act as agents of evolution for host genomes and the interaction between bacteriophage evolution and population structure.

As well as his formidable body of research, Campbell is also noted for his extraordinary commitment to the profession of microbiology as an author, educator, an
'"/>

Contact: Barbara Hyde
bhyde@asmusa.org
202-942-9206
American Society for Microbiology
30-Apr-2004


Page: 1 2

Related biology news :

1. Campbell to receive American Society for Microbiology lifetime achievement award
2. Edward C. Roy Jr. to receive Ian Campbell award
3. International Study Finds Mothers Lifetime Lead Exposures May Put Breast-Fed Newborns At Risk
4. Stanford Microbiologist Receives Lifetime Achievement Award
5. U.S. Scientists Honored For Lifetime Contributions In Hepatitis Research
6. University Of Chicago Professor Wins $50,000 Bristol-Myers Squibb Award For Distinguished Achievement In Infectious Disease Research
7. Gladstone investigator Mike McCune wins prestigious NIH Directors Pioneer Award
8. UT Southwestern biochemist honored with NIH Directors Pioneer Award
9. Award winning researchers reveal potential new role for Glivec
10. UMaine anthropologist wins Solon T. Kimball Award
11. Secretary of Energy announces seven E.O. Lawrence Award Winners

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Campbell wins Abbott ASM Lifetime Achievement Award

(Date:5/18/2013)... Research presented today at Digestive Disease Week (DDW) ... about the impact of coffee on autoimmune disease and ... consumption recently has been associated with reduced risk of ... more cups of java each month also correlate with ... at the Mayo Clinic, Rochester, MN, linked coffee consumption ...
(Date:5/18/2013)... An increasing number of U.S. children are ... according to research presented at Digestive Disease Week ... researchers at the Cleveland Clinic Children,s Hospital found ... exhaled breath compared to their lean counterparts. The ... that can be correlated to potential complications associated ...
(Date:5/17/2013)... insects provide the white noise of the South, but the ... the Southern air hangs heavy from the humidity and the ... than 140 species of frogs, toads and salamanders, is the ... ponds and swamps are the auditorium for their symphonic choruses, ... Monitoring Initiative, or ARMI, have front-row seats. , ...
Breaking Biology News(10 mins):Coffee consumption associated with reduced risk of autoimmune liver disease 2New research identifies risks, interventions for children's GI health 2New research identifies risks, interventions for children's GI health 3Front-row seats to climate change 2Front-row seats to climate change 3Front-row seats to climate change 4
(Date:5/21/2013)... TX (PRWEB) May 21, 2013 Smarter ... outdoor security solutions, today announced that Genzyme, a Sanofi ... units of Door Detective® CL for a multi-use facility ... installed in four other Genzyme buildings, this latest order ... with the tailgate detection device improving doorway ...
(Date:5/21/2013)... 2013  MacroGenics, Inc. today announced that an ... an Fc-modified chimeric monoclonal antibody (MAb), in patients ... will be presented at the 2013 Annual Meeting ... the Developmental Therapeutics - Immunotherapy Oral Abstract Session ... PM.  The presentation will describe the results of ...
(Date:5/21/2013)... May 21, 2013 NANONEX CORPORATION, ... solutions , today announced the successful delivery and ... system, the NX-M200B, to a major Japanese manufacturing ... a fully-automated, production-ready, advanced nanoimprint lithography tool that ... wafer and substrate sizes and types. Based on ...
(Date:5/21/2013)... 2013 PathoGenetix, Inc., a commercial-stage developer ... announced today that it has successfully identified and strain ... obtained from the Centers for Disease Control and Prevention ... The findings are detailed in a poster ... for Microbiology in Denver on Monday. , The 250 ...
Breaking Biology Technology:Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 3MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3Nanonex Announces the Shipment and Installation of an Innovative Nanoimprint Lithography System for Fully Automated Manufacturing 2New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 2New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 3
Cached News: